NCT04558710 is a clinical trial in Type 1 Diabetes, sponsored by University of Ljubljana, Faculty of Medicine.

Who is sponsoring NCT04558710?

NCT04558710 is sponsored by University of Ljubljana, Faculty of Medicine.

What condition does NCT04558710 study?

NCT04558710 studies Type 1 Diabetes, Continuous Glucose Monitoring, Children, Glucose Variability.

Is NCT04558710 still recruiting?

NCT04558710 is currently completed. Last updated 10 May 2023.

Last reviewed 2023-05-10 · How we verify

NCT04558710

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Frequent Continuous Glucose Monitoring Use on Glucose Variability in Preschoolers With Type 1 Diabetes

Completed Last updated 10 May 2023

What this trial tests

trial in Type 1 Diabetes in 339 participants. Completed in 30 December 2019.

Timeline

1 June 2018

Primary endpoint
30 September 2019

30 December 2019

Quick facts

Lead sponsor	University of Ljubljana, Faculty of Medicine
Status	Completed
Study type	OBSERVATIONAL
Enrollment	339
Start date	1 June 2018
Primary completion	30 September 2019
Estimated completion	30 December 2019
Sites	1 location across Slovenia

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →
Continuous Glucose Monitoring — all drugs for Continuous Glucose Monitoring →
Children — all drugs for Children →
Glucose Variability — all drugs for Glucose Variability →

Sponsor

University of Ljubljana, Faculty of Medicine

Who can join

Adults 1 to 7, any sex, with Type 1 Diabetes or Continuous Glucose Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether continuous glucose monitoring will improve glucose variability as measured by the coefficient of variation of glucose levels in very young children with T1D. The study adopts an open-label, multi-centre, multinational, prospective registry-based population cohort design contrasting CGM use to SMBG alone in young children with type 1 diabetes over 12 months. The primary endpoint is the difference between treatment modalities (CGM vs SMBG alone) in glycaemic variability, measured as the coefficient of variation of glucose levels, during the 12 months observational period. Other Key edpoints include time in range 70-180 mg/dl, time below range 70 mg/dl and time above range 180 mg/dl.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other University of Ljubljana, Faculty of Medicine trials

Trials by the same sponsor.

NCT05866900 — The Impact of Daily Carbohydrate Intake on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using an Ad · unknown
NCT04853030 — Fast Advanced Closed-Loop Therapy · NA · completed
NCT04252105 — Antioxidant-rich Diet and Oxidative Stress in Healthy Preschoolers · NA · completed
NCT04454827 — Fear of Hypoglycemia in Children and Adolecents With Type 1 Diabetes · completed
NCT04507984 — Universal Familial Hypercholesterolemia Screening in Children · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04558710 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Ljubljana, Faculty of Medicine
Last refreshed: 10 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04558710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing